Purple Biotech Ltd. (PPBT) - Operatsion marja

Purple Biotech (PPBT) korporativ emblemasi va logotipi

Purple Biotech Isroilda joylashgan markazlari qattiq o'smalardagi qarshilikka qarshi kurashish uchun davolash usullarini ishlab chiqmoqda. Operatsion foyda marjasi samaradorlik dinamikasini aks ettiradi va ushbu ko'rsatkich hozirda 0.00 darajasida. PhD mutaxassislaridan iborat ilmiy xodimlar maqsadli terapiyalarni yaratayotgan bo'lsalar-da, yuqori R&D xarajatlari va klinik sinovlar xatarlari kompaniyani qo'shimcha kapital jalb qilishga majbur qilmoqda, bu esa aksiyalar qiymatining kamayishiga (dilution) olib kelishi mumkin.

PPBT - purple-biotech.com Operatsion foyda normasi 04.07.2022 - 19.11.2026 oraligʻida

PPBT (purple-biotech.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Purple Biotech Ltd.
Purple Biotech tayyor mahsulotlari

Operatsion marja tushumga nisbatan asosiy biznes jarayonlaridan foyda olish samaradorligini aks ettiradi va moliyaviy majburiyatlar hisobga olinishidan oldin aktivning savdoni operatsion daromadga aylantirish qobiliyatini namoyish etadi. Hisoblangan operatsion marjaning tahlili Purple Biotech (PPBT) kompaniyasining onkologik dori vositalarini ishlab chiqish xarajatlariga chidamliligini baholash imkonini beradi, bunda ushbu ko'rsatkichning yuqori tebranishlari R&D xarajatlari va kapitalning suyulishi xavfi o'rtasidagi kritik muvozanatdan dalolat beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja